Patients

PharmaMar collaboration activities with the following patients associations

Search Location

Presencia Internacional: 0
Loading...

Directions

Get Your Directions

Show Distance In

Use my location to find the closest Service Provider near me

2018

More information about the collaborations

2017

More information about the collaborations

2016

More information about the collaborations

2015

More information about the collaborations

2014

More information about the collaborations

Oncology pipeline

PharmaMar develops and commercializes YONDELIS® in Europe and has three clinical-stage drug candidates under development for several types of solid and hematological cancers, Aplidin ®, Lurbinectedin, and PM184.

Shareholders and Investors

Financial Information of the Company, stock information, official notices to the CNMV (Spanish Securities & Exchange Commission), product portfolio and other information.

Newsroom

If you need information about the company, our clinical trials, corporate images or multimedia, visit our newsroom